机构:[1]Laboratory of Biochemistry and Molecular Biology, School of Life Science, Yunnan University, Kunming, China[2]Department of Pathology, First Peoples Hospital of Yunnan Province, Kunming, China医技片病理科云南省第一人民医院
Human arrest-defective-1 (hARD1) was reported to be important in regulating cell cycle and promoting lung cancer cell proliferation. Here we have investigated the correlation between hARD1 and breast cancer. Analysis with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry (FCM) demonstrated that overexpression of hARD1 was associated with increased proliferation of MCF-7 cell, a human breast cancer cell line. Western blotting and immunohistochemical staining assay showed that hARD1 presented higher in breast cancer tissue than the adjacent tissue; accumulation of hARD1 protein was higher in 86% (37/43) of breast cancer, far more than noncancer samples. Our results suggest that hARD1 might play an important role in breast cancer carcinogenesis.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [30360040]; Science & Technological Key Project of Yunnan Province [2006SG09]
第一作者机构:[1]Laboratory of Biochemistry and Molecular Biology, School of Life Science, Yunnan University, Kunming, China
通讯作者:
通讯机构:[1]Laboratory of Biochemistry and Molecular Biology, School of Life Science, Yunnan University, Kunming, China[*1]Laboratory of Biochemistry and Molecular Biology School of Life Sciences Yunnan University 650091 Kunming, China
推荐引用方式(GB/T 7714):
Yu Min,Ma MingXing,Huang Chao,et al.Correlation of Expression of Human Arrest-Defective-1 (hARD1) Protein With Breast Cancer[J].CANCER INVESTIGATION.2009,27(10):978-983.doi:10.3109/07357900902769723.
APA:
Yu, Min,Ma, MingXing,Huang, Chao,Yang, Hui,Lai, JianHua...&Tan, DeYong.(2009).Correlation of Expression of Human Arrest-Defective-1 (hARD1) Protein With Breast Cancer.CANCER INVESTIGATION,27,(10)
MLA:
Yu, Min,et al."Correlation of Expression of Human Arrest-Defective-1 (hARD1) Protein With Breast Cancer".CANCER INVESTIGATION 27..10(2009):978-983